-
Mar 23, 2021, 01:00
by
admin admin
On March 23, the Colorado Society of Addiction Medicine (COSAM) submitted a letter in support of SB21-137, which would provide or extend funding for addiction prevention, treatment, and recovery efforts in Colorado
Full story
-
Mar 22, 2021, 01:00
by
admin admin
Leading medical organizations representing addiction specialists call on Congress to enact critical funding and legislative measures to prevent and treat addiction, promote recovery, and save lives.
Full story
-
Mar 18, 2021, 01:00
by
admin admin
With a recent survey indicating only 1 in 4 healthcare providers having ever received training on addiction during medical education, Congress must pass the bipartisan MATE Act to ensure DEA-licensed prescribers have a baseline knowledge of how to treat and manage patients with substance use disorder
Full story
-
Mar 17, 2021, 01:00
by
admin admin
With overdose deaths at record levels, addiction medicine advocates encourage Congress to adopt bold policies to advance addiction medicine and save lives.
Full story
-
Mar 17, 2021, 01:00
by
admin admin
The American Society of Addiction Medicine (ASAM) and 53 other organizations sent Rep. Lisa Blunt Rochester (D-DE) a letter of support for the Quit Because of COVID-19 Act.
Full story
-
Mar 11, 2021, 01:00
by
admin admin
The American Society of Addiction Medicine (ASAM) commended President Biden for signing the American Rescue Plan Act of 2021 into law. The American Rescue Plan Act contains several important provisions that will expand Americans’ access to addiction prevention, treatment, harm reduction and recovery support services and increase addiction workforce training.
Full story
-
Feb 26, 2021, 01:00
by
admin admin
On February 25th, the American Society of Addiction Medicine (ASAM) issued a Public Policy Statement on Advancing Racial Justice in Addiction Medicine , the first in a series of statements on addressing the systemic racism that permeates drug policy and impacts both the development of addiction as well as access to treatment for millions of Americans with substance use disorder (SUD). Recognizing systemic racism as a social determinant of health, the public policy statement released today is part of ASAM’s effort to recognize, understand, and counteract the effects of America’s historical, pervasive, and continuing systemic racism as it relates to addiction prevention, early intervention, diagnosis, treatment, and recovery.
Full story
-
Feb 25, 2021, 01:00
by
admin admin
ASAM supports passage of legislation that would fully eliminate the X-waiver, which creates an unnecessary barrier for prescribing buprenorphine for opioid use disorder (OUD), with passage of complementary legislation that would ensure controlled medication prescribers receive baseline education and training on how to treat patients with substance use disorder (SUD).
Full story
-
Feb 25, 2021, 01:00
by
admin admin
The Minnesota Society of Addiction Medicine (MNSAM) submitted a letter in support of HF928, which would legalize possession of fentanyl testing strips, and empower syringe service providers to more effectively serve their clients by providing syringes and needles.
Full story
-
Feb 23, 2021, 01:00
by
admin admin
On February 23, the Colorado Society of Addiction Medicine (COSAM) submitted comments on the Colorado Division of Insurance’s Proposed New Regulation 4-2-7X,. The regulation would implement stringent reporting requirements on insurers in Colorado which are intended to improve the DOI’s ability to judge the network adequacy of insurers when covering treatment for substance use disorders (SUD).
Full story
-
Feb 16, 2021, 01:00
by
admin admin
On February 16, ASAM along with 15 partner organizations representing healthcare professionals, patients and advocates dedicated to the prevention and treatment of substance use disorder (SUD), wrote to the Office of the Inspector General at the Department of Health and Human Services calling for the creation of a new safe harbor provision to the Federal Anti-kickback Statute (AKS) to protect the use of cash and cash-equivalent payments offered as part of contingency management (CM) in the treatment of SUD. CM is an evidence-based, psychosocial intervention that involves giving patients tangible monetary or non-monetary rewards (such as gift cards or vouchers) to reinforce positive behaviors such as treatment adherence (e.g., participation in therapy sessions, attendance at scheduled appointments, medication adherence) or reduced drug use/abstinence from drug use.
Full story
-
Feb 12, 2021, 01:00
by
admin admin
On February 12, the Utah Society of Addiction Medicine (UTSAM) submitted a letter in opposition to SB170, which would establish a new provider type under Utah’s medical cannabis law.
Full story
-
Feb 11, 2021, 01:00
by
admin admin
On February 11, the Michigan Society of Addiction Medicine (MISAM) submitted comments on a proposed policy, 2067-AUD/OUD, released by the Michigan Department of Health and Human Services (MDHHS) which would expand Medicaid reimbursement options for clinicians in Michigan who treat addiction outside of the state’s separate Medicaid behavioral health system
Full story
-
Feb 11, 2021, 01:00
by
admin admin
On February 11, the Northwest Society of Addiction Medicine (NWSAM) sent a letter to state legislators in support of SB2179, which would expand access to telehealth services in North Dakota.
Full story
-
Jan 27, 2021, 01:00
by
admin admin
New guidelines endorsed by more than 30 leading health groups, including the American Medical Association, call for focus on addiction treatment and prevention, avoid diversion of funds to close budget gaps.
Full story
-
Jan 26, 2021, 01:00
by
admin admin
Treatment professional and addiction-related advocacy groups urge Congress to eliminate the X-waiver, which creates an unnecessary barrier to prescribing buprenorphine, and to prioritize education for addiction treatment.
Full story
-
Jan 21, 2021, 01:00
by
admin admin
The Minnesota Society of Addiction Medicine (MNSAM) submitted a letter of support for SF61/HF19, companion bills which would remove the “buy and bill” requirement from all practitioner administered medications for substance use disorders (SUD).
Full story
-
Jan 8, 2021, 01:00
by
admin admin
ASAM released its 2020 Advocacy Year in Review, which provides an overview of some of the new policies and resources that ASAM and its State Chapters helped advance in 2020, by working closely with federal and state policy-makers and other key stakeholders.
Full story
-
Jan 6, 2021, 01:00
by
admin admin
The Kentucky Society of Addiction Medicine (KYSAM) sent a letter to the Kentucky Board of Nursing, expressing KYSAM’s strong support for the Advanced Practice Registered Nurse (APRN) Council’s recommended amendments to Kentucky’s professional standards for Kentucky APRNs who prescribe buprenorphine for the treatment of opioid use disorder (OUD). With the opioid addiction and overdose epidemic significantly impacting the country and Kentucky, KYSAM greatly appreciated the APRN Council’s efforts to increase access to evidence-based OUD treatment and encouraged the Kentucky Board of Nursing to adopt the APRN Council’s recommendations.
Full story
-
Jan 4, 2021, 01:00
by
admin admin
The American Society of Addiction Medicine (ASAM), sent a letter to provide comments on the Interim Final Rule on the Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment (the “Interim Final Rule”).
Full story